Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients
about
State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinicianPlasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant RecipientsThe human cytomegalovirus glycoprotein pUL11 acts via CD45 to induce T cell IL-10 secretion.The immune response to human CMVImmune response to CMV in solid organ transplant recipients: current concepts and future directions.Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplant.MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.ABO desensitization affects cellular immunity and infection control after renal transplantation.Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation.
P2860
Q27014778-4890DBC7-2A5E-4603-B0E0-0779CFAFBCF9Q36389162-DE50A876-0975-4A16-B2F4-CB12A72A1405Q36409239-E83030F1-A9F6-4796-B32B-4549E91BBA95Q36517022-A12A408A-9B06-47A3-813A-2BBD15D51403Q38011227-8FF895DB-425C-4A8F-B00C-19FE62A3F5B8Q39037833-3A67364A-7957-41CC-8C74-E5C2003FB55FQ40497816-4756028C-FB92-4310-9229-DC63B2E4D7C0Q40763966-28B44397-2886-4124-89E9-A3F356C33CE7Q40879749-8E0B007F-E22C-42AE-ACE3-80FCFDAC63FEQ41089597-3E305780-5E6F-49C1-B183-59CFBF58D83AQ41128262-5412FD05-508A-462F-9F2A-BA5E1337C773Q42030698-599F0546-FEE4-4C59-838D-8E7C5735C6A2
P2860
Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Primary response against cytom ...... id organ transplant recipients
@ast
Primary response against cytom ...... id organ transplant recipients
@en
type
label
Primary response against cytom ...... id organ transplant recipients
@ast
Primary response against cytom ...... id organ transplant recipients
@en
prefLabel
Primary response against cytom ...... id organ transplant recipients
@ast
Primary response against cytom ...... id organ transplant recipients
@en
P2093
P2860
P1476
Primary response against cytom ...... id organ transplant recipients
@en
P2093
Ajit P Limaye
Aparna Krishnan
Corinna La Rosa
Gideon Blumstein
P2860
P304
P356
10.1111/J.1432-2277.2011.01285.X
P577
2011-06-14T00:00:00Z